Enter at least 4 characters

3 results showing for: 'umeclidinium'

Fluticasone furoate with umeclidinium and vilanterol    Medsafe Data Sheets   New Zealand Formulary.   Hospital Medicines List.   PDF Schedule - Refer from page 254.
- Special Authority SA2326 -- Retail pharmacy
  • Powder for inhalation fluticasone furoate 100 mcg with umeclidinium 62.5 mcg and vilanterol 25 mcg
    • Brand Fully subsidised brand. Trelegy Ellipta
    • Pharmacode2674904
    • Subsidy $104.24
    • Measure / Qty per 30 dose OP
- Subsidy by endorsement
  • Powder for inhalation 62.5 mcg per dose
    • Brand Fully subsidised brand. Incruse Ellipta
    • Pharmacode2494280
    • Subsidy $61.50
    • Measure / Qty per 30 dose OP

Umeclidinium will not be subsidised if patient is also receiving treatment with subsidised inhaled glycopyrronium or tiotropium bromide.

Umeclidinium powder for inhalation 62.5 mcg per dose is subsidised only for patients who have been diagnosed as having COPD using spirometry if spirometry is possible, and the prescription is endorsed accordingly.

- Special Authority SA1584 -- Retail pharmacy
  • Powder for inhalation 62.5 mcg with vilanterol 25 mcg
    • Brand Fully subsidised brand. Anoro Ellipta
    • Pharmacode2494272
    • Subsidy $77.00
    • Measure / Qty per 30 dose OP

Combination long acting muscarinic antagonist and long acting beta-2 agonist will not be subsidised if patient is also receiving treatment with a combination inhaled corticosteroid and long acting beta-2 agonist.

  • Rectangle page icon symoblising a PDF. PDF
  • A tick icon. Fully subsidised
  • An oval with the number 29 in it. Unapproved medicine under Section 29
  • An asterisk symbol. 3 or 6 months should be dispensed at once
  • Two duplicate pages icon. Click to copy
  • A triangle symbol. Three months supply may be dispensed at one time if endorsed "certified exemption" by the prescriber or pharmacist.
  • OP Original pack
  • Sole Subsidised Supply